PEGS Boston 2018 | Discovery of High-Affinity Human PD-1 and LAG-3 Antibodies

from CHI Podcasts · host Cambridge Healthtech Podcasts

Cambridge Healthtech Institute’s Kent Simmons recently spoke with Dr. David Johnson, CEO of GigaGen, about his upcoming presentation “Discovery of High-Affinity Human PD-1 and LAG-3 Antibodies Using Novel Microfluidic and Molecular Genomic Methods”, to be delivered in the Engineering Antibodies meeting at the 2018 PEGS Boston. PEGS is scheduled for April 30 - May 4, 2018 in Boston, with the antibodies program set for May 2-3. For more information, please visit http://www.PEGSummit.com/Engineering-Antibodies

Episode metadata supplied by the publisher feed · Published Feb 20, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

PEGS Boston 2018 | Discovery of High-Affinity Human PD-1 and LAG-3 Antibodies

0:00 10:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CHI Podcasts?

This episode is 10 minutes long.

When was this CHI Podcasts episode published?

This episode was published on February 20, 2018.

Can I download this CHI Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!